Sweet S C, Wong H-H, Webber S A, Horslen S, Guidinger M K, Fine R N, Magee J C
Washington University School of Medicine, St. Louis, MO, USA.
Am J Transplant. 2006;6(5 Pt 2):1132-52. doi: 10.1111/j.1600-6143.2006.01271.x.
This article reviews trends in pediatric solid organ transplantation over the last decade, as reflected in OPTN/SRTR data. In 2004, children younger than 18 years made up nearly 3% of the 86,378 candidates for organ transplantation and nearly 7% of the 27,031 organ transplant recipients. Children accounted for nearly 14% of the 7152 deceased organ donors. The transplant community recognizes important differences between pediatric and adult organ transplant recipients, including different etiologies of organ failure, surgical procedures that are more complex or technically challenging, effects of development on the pharmacokinetic properties of common immunosuppressants, unique immunological aspects of transplant in the developing immune system and increased susceptibility to posttransplant complications, particularly infectious diseases. For these reasons, and because of the impact of end-stage organ failure on growth and development, the transplant community has generally provided pediatric candidates with special consideration in the allocation of deceased donor organs. Outcomes following kidney, liver and heart transplantation in children often rank among the best. This article emphasizes that the prospects for solid organ transplantation in children, especially those aged 1-10 years are excellent. It also identifies themes warranting further consideration, including organ availability, adolescent survival and challenges facing pediatric transplant clinical research.
本文回顾了过去十年儿科实体器官移植的趋势,这在器官获取与移植网络(OPTN)/器官共享联合网络(SRTR)的数据中有所体现。2004年,18岁以下儿童占86378名器官移植候选者的近3%,占27031名器官移植受者的近7%。儿童占7152名已故器官捐献者的近14%。移植界认识到儿科和成人器官移植受者之间存在重要差异,包括器官衰竭的不同病因、更复杂或技术要求更高的外科手术、发育对常用免疫抑制剂药代动力学特性的影响、发育中的免疫系统移植的独特免疫学方面以及移植后并发症,特别是传染病易感性增加。出于这些原因,并且由于终末期器官衰竭对生长发育的影响,移植界在已故供体器官分配中通常会对儿科候选者给予特殊考虑。儿童肾、肝和心脏移植后的结果通常名列前茅。本文强调,儿童,尤其是1至10岁儿童实体器官移植的前景非常好。它还确定了值得进一步考虑的主题,包括器官供应、青少年存活率以及儿科移植临床研究面临的挑战。